Gibson Christopher's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Mar 10, 2023
- Accession no.
- 0001209191-23-017918
- Filed
- Mar 10, 2023
- Trade date
- Mar 8-9, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 4 derivative transactions. Open-market sales total $893.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gibson ChristopherCIK 0001856369 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Class A Common Stock | MOption exerciseAcquired | +93,750 | $2.48 | +$232,500 | 1,034,677 | Direct | |
| Mar 8, 2023 | Class A Common Stock | SSaleDisposed | −70,890 | $8.10F2 | −$574,209 | 963,787 | Direct | |
| Mar 8, 2023 | Class A Common Stock | GGiftDisposed | −10,000 | $0.00 | $0 | 953,787 | Direct | |
| Mar 8, 2023 | Class A Common Stock | CConversionAcquired | +4,000 | $0.00 | $0 | 4,000 | Indirect | |
| Mar 8, 2023 | Class A Common Stock | SSaleDisposed | −4,000 | $8.09F5 | −$32,360 | 0 | Indirect | |
| Mar 8, 2023 | Class A Common Stock | CConversionAcquired | +20,000 | $0.00 | $0 | 20,000 | Indirect | |
| Mar 8, 2023 | Class A Common Stock | SSaleDisposed | −20,000 | $8.10F7 | −$162,000 | 0 | Indirect | |
| Mar 8, 2023 | Class A Common Stock | CConversionAcquired | +1,000 | $0.00 | $0 | 1,000 | Indirect | |
| Mar 8, 2023 | Class A Common Stock | SSaleDisposed | −1,000 | $8.09F9 | −$8,090 | 0 | Indirect | |
| Mar 9, 2023 | Class A Common Stock | SSaleDisposed | −15,000 | $7.77F10 | −$116,550 | 938,787 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Class A Common Stock | MOption exerciseDisposed | −93,750 | $0.00 | $0 | 687,500 | Direct | |
| Mar 8, 2023 | Class A Common Stock | CConversionDisposed | −4,000 | $0.00 | $0 | 535,000 | Indirect | |
| Mar 8, 2023 | Class A Common Stock | CConversionDisposed | −20,000 | $0.00 | $0 | 508,000 | Indirect | |
| Mar 8, 2023 | Class A Common Stock | CConversionDisposed | −1,000 | $0.00 | $0 | 123,875 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $7.98 to $8.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $8.02 to $8.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $7.98 to $8.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $8.03 to $8.28. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $7.46 to $8.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.